A citation-based method for searching scientific literature

Denis Horgan, Marleen Jansen, Lada Leyens, Jonathan A Lal, Ralf Sudbrak, Erica Hackenitz, Ulrike Bußhoff, Wolfgang Ballensiefen, Angela Brand. Public Health Genomics 2014
Times Cited: 41







List of co-cited articles
102 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Working towards personalization in medicine: main obstacles to reaching this vision from today's perspective.
Lada Leyens, Denis Horgan, Jonathan A Lal, Kirsten Steinhausen, Kapaettu Satyamoorthy, Angela Brand. Per Med 2014
7
71

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Henry M Dunnenberger, Kristine R Crews, James M Hoffman, Kelly E Caudle, Ulrich Broeckel, Scott C Howard, Robert J Hunkler, Teri E Klein, William E Evans, Mary V Relling. Annu Rev Pharmacol Toxicol 2015
229
12

Implementation and utilization of genetic testing in personalized medicine.
Noura S Abul-Husn, Aniwaa Owusu Obeng, Saskia C Sanderson, Omri Gottesman, Stuart A Scott. Pharmgenomics Pers Med 2014
43
9

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.
A R Shuldiner, M V Relling, J F Peterson, J K Hicks, R R Freimuth, W Sadee, N L Pereira, D M Roden, J A Johnson, T E Klein,[...]. Clin Pharmacol Ther 2013
108
9

Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
237
9

Clinical application of pharmacogenetics.
B B Spear, M Heath-Chiozzi, J Huff. Trends Mol Med 2001
256
9

Health data cooperatives - citizen empowerment.
E Hafen, D Kossmann, A Brand. Methods Inf Med 2014
43
9


Evidence based medicine: what it is and what it isn't.
D L Sackett, W M Rosenberg, J A Gray, R B Haynes, W S Richardson. BMJ 1996
9

Is precision medicine the route to a healthy world?
Denis Horgan, Angelo Paradiso, Gordon McVie, Ian Banks, Tom Van der Wal, Angela Brand, Mark Lawler. Lancet 2015
12
33

Implementing genomic medicine in the clinic: the future is here.
Teri A Manolio, Rex L Chisholm, Brad Ozenberger, Dan M Roden, Marc S Williams, Richard Wilson, David Bick, Erwin P Bottinger, Murray H Brilliant, Charis Eng,[...]. Genet Med 2013
307
9

Pharmacogenomic information in drug labels: European Medicines Agency perspective.
F Ehmann, L Caneva, K Prasad, M Paulmichl, M Maliepaard, A Llerena, M Ingelman-Sundberg, M Papaluca-Amati. Pharmacogenomics J 2015
71
9

Personalised medicine: the cognitive side of patients.
Ilaria Cutica, Gordon Mc Vie, Gabriella Pravettoni. Eur J Intern Med 2014
27
11

Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
528
7


Pharmacogenetics in Europe: barriers and opportunities.
D Gurwitz, E Zika, M M Hopkins, S Gaisser, D Ibarreta. Public Health Genomics 2009
35
8

Ask not what personalized medicine can do for you--ask what you can do for personalized medicine.
Isabelle Budin-Ljøsne, Jennifer R Harris. Public Health Genomics 2015
12
25

Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU).
Kristine Sørensen, Jürgen M Pelikan, Florian Röthlin, Kristin Ganahl, Zofia Slonska, Gerardine Doyle, James Fullam, Barbara Kondilis, Demosthenes Agrafiotis, Ellen Uiters,[...]. Eur J Public Health 2015
436
7

A tiered-layered-staged model for informed consent in personal genome testing.
Eline M Bunnik, A Cecile J W Janssens, Maartje H N Schermer. Eur J Hum Genet 2013
48
7


What is personalized medicine: sharpening a vague term based on a systematic literature review.
Sebastian Schleidgen, Corinna Klingler, Teresa Bertram, Wolf H Rogowski, Georg Marckmann. BMC Med Ethics 2013
87
7


How many molecular subtypes? Implications of the unique tumor principle in personalized medicine.
Shuji Ogino, Charles S Fuchs, Edward Giovannucci. Expert Rev Mol Diagn 2012
101
7



European healthcare systems readiness to shift from 'one-size fits all' to personalized medicine.
Sebastian Schee Genannt Halfmann, Nikolaos Evangelatos, Peter Schröder-Bäck, Angela Brand. Per Med 2017
5
60

Barriers for integrating personalized medicine into clinical practice: a qualitative analysis.
Mehdi Najafzadeh, Jennifer C Davis, Pamela Joshi, Carlo Marra. Am J Med Genet A 2013
17
17

The theory of reference values: an unfinished symphony.
Gerard Siest, Joseph Henny, Ralph Gräsbeck, Peter Wilding, Claude Petitclerc, Josep M Queraltó, Peter Hyltoft Petersen. Clin Chem Lab Med 2013
52
4

Whole genome sequencing as a diagnostic test: challenges and opportunities.
Caitlin C Chrystoja, Eleftherios P Diamandis. Clin Chem 2014
41
4

Awareness regarding clinical application of pharmacogenetics among Japanese pharmacists.
Taku Obara, Shinya Abe, Michihiro Satoh, Sergio Ramón Gutiérrez Ubeda, Shoko Yoshimachi, Teruaki Goto. Pharmgenomics Pers Med 2015
6
33

Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine.
Minhaz Uddin Ahmed, Ishtiaq Saaem, Pae C Wu, April S Brown. Crit Rev Biotechnol 2014
57
4

miRNAs as biomarkers of myocardial infarction: a step forward towards personalized medicine?
Emeline Goretti, Daniel R Wagner, Yvan Devaux. Trends Mol Med 2014
56
4

Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO).
F Ciardiello, D Arnold, P G Casali, A Cervantes, J-Y Douillard, A Eggermont, A Eniu, K McGregor, S Peters, M Piccart,[...]. Ann Oncol 2014
64
4


Clinical necessity of partitioning of human plasma haptoglobin reference intervals by recently-discovered rs2000999.
Payman Shahabi, Gérard Siest, Bernard Herbeth, Ndeye Coumba Ndiaye, Sophie Visvikis-Siest. Clin Chim Acta 2012
11
18

Laboratory medicine: challenges and opportunities.
Xavier Bossuyt, Kurt Verweire, Norbert Blanckaert. Clin Chem 2007
45
4

Challenges and opportunities for medical directors in pathology and laboratory medicine: standardization, integration, and innovation.
Subhash C Arya, James S Hernandez, Jane C Dale, Kevin E Bennet, Prathibha Varkey. Am J Clin Pathol 2010
3
66

The highs and lows of tumor biomarkers: lost illusions.
Bohuslav Melichar. Clin Chem Lab Med 2015
3
66

Personalized (laboratory) medicine: a bridge to the future.
Mario Plebani, Giuseppe Lippi. Clin Chem Lab Med 2013
15
13

Mass spectrometry-based proteomics in Chest Medicine, Gerontology, and Nephrology: subgroups omics for personalized medicine.
Shih-Yi Lin, Wu-Huei Hsu, Cheng-Chieh Lin, Chao-Jung Chen. Biomedicine (Taipei) 2014
12
16

Inter-individual variation of inflammatory markers of cardiovascular risks and diseases.
Hind Berrahmoune, John Lamont, Peter Fitzgerald, Sophie Visvikis-Siest. Clin Chem Lab Med 2005
13
15

Biomedical research: increasing value, reducing waste.
Malcolm R Macleod, Susan Michie, Ian Roberts, Ulrich Dirnagl, Iain Chalmers, John P A Ioannidis, Rustam Al-Shahi Salman, An-Wen Chan, Paul Glasziou. Lancet 2014
412
4

Policies to aid the adoption of personalized medicine.
Charity Nofziger, Marisa Papaluca, Andre Terzic, Scott Waldman, Markus Paulmichl. Nat Rev Drug Discov 2014
5
40

Personalized medicine and the clinical laboratory.
João Renato Rebello Pinho, Roberta Sitnik, Cristóvão Luis Pitangueira Mangueira. Einstein (Sao Paulo) 2014
4
50

Omics and drug response.
Urs A Meyer, Ulrich M Zanger, Matthias Schwab. Annu Rev Pharmacol Toxicol 2013
86
4

Pharmacogenomics and individualized medicine: translating science into practice.
K R Crews, J K Hicks, C-H Pui, M V Relling, W E Evans. Clin Pharmacol Ther 2012
129
4


Clinical pharmacogenetics implementation: approaches, successes, and challenges.
Kristin W Weitzel, Amanda R Elsey, Taimour Y Langaee, Benjamin Burkley, David R Nessl, Aniwaa Owusu Obeng, Benjamin J Staley, Hui-Jia Dong, Robert W Allan, J Felix Liu,[...]. Am J Med Genet C Semin Med Genet 2014
119
4

Meaningful use of pharmacogenetics.
M J Ratain, J A Johnson. Clin Pharmacol Ther 2014
15
13

Pharmacogenomics knowledge for personalized medicine.
M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein. Clin Pharmacol Ther 2012
777
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.